Article info

Download PDFPDF
Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion

Authors

  1. Correspondence to Dr Masahiko Shimura, Department of Ophthalmology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo 193-0998, Japan; masahiko{at}v101.vaio.ne.jp
View Full Text

Citation

Shimura M, Yasuda K
Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion

Publication history

  • Received December 3, 2013
  • Revised May 13, 2014
  • Accepted August 9, 2014
  • First published September 2, 2014.
Online issue publication 
January 20, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.